261 IMG-007, a non-depleting anti-OX40 monoclonal antibody, reduced skin lesion severity and serum inflammatory markers in adults with moderate-to-severe atopic dermatitis in a Phase 1b/2a study
2025 · Journal of Investigative Dermatology · 0 citations
https://doi.org/10.1016/j.jid.2025.09.265